295 related articles for article (PubMed ID: 32718270)
1. Low glucose enhanced metformin's inhibitory effect on pancreatic cancer cells by suppressing glycolysis and inducing energy stress via up-regulation of miR-210-5p.
Ma M; Ma C; Li P; Ma C; Ping F; Li W; Xu L; Zhang H; Sun Q; Li Y
Cell Cycle; 2020 Sep; 19(17):2168-2181. PubMed ID: 32718270
[TBL] [Abstract][Full Text] [Related]
2. Knockdown circZNF131 Inhibits Cell Progression and Glycolysis in Gastric Cancer Through miR-186-5p/PFKFB2 Axis.
Shen X; Zhu X; Hu P; Ji T; Qin Y; Zhu J
Biochem Genet; 2022 Oct; 60(5):1567-1584. PubMed ID: 35059934
[TBL] [Abstract][Full Text] [Related]
3. miR-21-5p inhibits the growth of brain glioma cells through regulating the glycolysis mediated by PFKFB2.
Zhang L; Liu J
Funct Integr Genomics; 2023 Oct; 23(4):322. PubMed ID: 37864733
[TBL] [Abstract][Full Text] [Related]
4. Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer.
Sha L; Lv Z; Liu Y; Zhang Y; Sui X; Wang T; Zhang H
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109434
[TBL] [Abstract][Full Text] [Related]
5. Metformin attenuates hepatoma cell proliferation by decreasing glycolytic flux through the HIF-1α/PFKFB3/PFK1 pathway.
Hu L; Zeng Z; Xia Q; Liu Z; Feng X; Chen J; Huang M; Chen L; Fang Z; Liu Q; Zeng H; Zhou X; Liu J
Life Sci; 2019 Dec; 239():116966. PubMed ID: 31626790
[TBL] [Abstract][Full Text] [Related]
6. Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells.
Tanaka R; Tomosugi M; Horinaka M; Sowa Y; Sakai T
PLoS One; 2015; 10(5):e0125779. PubMed ID: 25955843
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis.
Tu MJ; Duan Z; Liu Z; Zhang C; Bold RJ; Gonzalez FJ; Kim EJ; Yu AM
Mol Pharmacol; 2020 Dec; 98(6):686-694. PubMed ID: 33051382
[TBL] [Abstract][Full Text] [Related]
8. miR-149-5p protects against high glucose-induced pancreatic beta cell apoptosis via targeting the BH3-only protein BIM.
Ruan D; Liu Y; Wang X; Yang D; Sun Y
Exp Mol Pathol; 2019 Oct; 110():104279. PubMed ID: 31260649
[TBL] [Abstract][Full Text] [Related]
9. PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cells.
Ozcan SC; Sarioglu A; Altunok TH; Akkoc A; Guzel S; Guler S; Imbert-Fernandez Y; Muchut RJ; Iglesias AA; Gurpinar Y; Clem AL; Chesney JA; Yalcin A
Mol Cell Biochem; 2020 Jul; 470(1-2):115-129. PubMed ID: 32415418
[TBL] [Abstract][Full Text] [Related]
10. MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway.
Zhu JH; De Mello RA; Yan QL; Wang JW; Chen Y; Ye QH; Wang ZJ; Tang HJ; Huang T
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165747. PubMed ID: 32109492
[TBL] [Abstract][Full Text] [Related]
11. miR-597-5p inhibits cell growth and promotes cell apoptosis by targeting ELK1 in pancreatic cancer.
Li S; Li X; Xing X; Wang L
Hum Cell; 2020 Oct; 33(4):1165-1175. PubMed ID: 32613573
[TBL] [Abstract][Full Text] [Related]
12. miR-613 inhibits Warburg effect in gastric cancer by targeting PFKFB2.
Liu H; Chen K; Wang L; Zeng X; Huang Z; Li M; Dong P; Chen X
Biochem Biophys Res Commun; 2019 Jul; 515(1):37-43. PubMed ID: 31122697
[TBL] [Abstract][Full Text] [Related]
13. Glucose-deprivation increases thyroid cancer cells sensitivity to metformin.
Bikas A; Jensen K; Patel A; Costello J; McDaniel D; Klubo-Gwiezdzinska J; Larin O; Hoperia V; Burman KD; Boyle L; Wartofsky L; Vasko V
Endocr Relat Cancer; 2015 Dec; 22(6):919-32. PubMed ID: 26362676
[TBL] [Abstract][Full Text] [Related]
14. Metformin Induces Oxidative Stress-Mediated Apoptosis without the Blockade of Glycolysis in H4IIE Hepatocellular Carcinoma Cells.
Park D
Biol Pharm Bull; 2019; 42(12):2002-2008. PubMed ID: 31787716
[TBL] [Abstract][Full Text] [Related]
15. MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1.
Ma F; Zhang L; Ma L; Zhang Y; Zhang J; Guo B
J Exp Clin Cancer Res; 2017 Nov; 36(1):158. PubMed ID: 29132384
[TBL] [Abstract][Full Text] [Related]
16. miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect.
Li L; Kang L; Zhao W; Feng Y; Liu W; Wang T; Mai H; Huang J; Chen S; Liang Y; Han J; Xu X; Ye Q
Cancer Lett; 2017 Aug; 400():89-98. PubMed ID: 28461244
[TBL] [Abstract][Full Text] [Related]
17. [MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
Sun Y; Jin XL; Zhang TT; Jia CW; Chen J
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):460-4. PubMed ID: 24246865
[TBL] [Abstract][Full Text] [Related]
18. miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism.
Wu DH; Liang H; Lu SN; Wang H; Su ZL; Zhang L; Ma JQ; Guo M; Tai S; Yu S
Cell Physiol Biochem; 2018; 50(3):924-935. PubMed ID: 30355947
[TBL] [Abstract][Full Text] [Related]
19. MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.
Mou T; Xie F; Zhong P; Hua H; Lai L; Yang Q; Wang J
Biomed Pharmacother; 2019 Mar; 111():891-900. PubMed ID: 30841468
[TBL] [Abstract][Full Text] [Related]
20. miR-122-5p Restrains Pancreatic Cancer Cell Growth and Causes Apoptosis by Negatively Regulating ASCT2.
Ren P; Wu NA; Fu S; Wang W; Li QI; Cheng Q
Anticancer Res; 2023 Oct; 43(10):4379-4388. PubMed ID: 37772564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
